26 Viruses from the taxonomic family Hantaviridae are encountered as emerging 27 pathogens causing two life-threatening human zoonoses: hemorrhagic fever with renal 28 syndrome (HFRS) and hantavirus cardiopulmonary syndrome (HCPS) with case 29 fatalities of up to 50%. Here we comprehensively investigated entry of the Old-World 30 Hantavirus, Puumala virus (PUUV), into mammalian cells, showing that upon treatment 31 with pharmacological inhibitors of macropinocytosis and clathrin-mediated 32 endocytosis, PUUV infections are significantly reduced. We demonstrated that the 33 inhibitors did not interfere with viral replication and that RNA interference, targeting 34 cellular mediators of macropinocytosis, is able to decrease PUUV infection levels 35 significantly. Moreover, we established lipophilic tracer staining of PUUV virus particles 36 and showed co-localization of stained virions and markers of macropinocytic uptake.
140 by 40 cycles of an annealing temperature of 95 °C for 5 seconds, amplification at 60 141°C for 30 seconds, and finished by denaturation at 95 °C for 15 seconds. 292 Rottlerin, that interfere with macropinocytosis by two different mechanisms ( Figure 3A) .
293 EIPA inhibits a Na + /H + exchanger that is involved in the formation of macropinosomes, 294 whereas Rottlerin specifically blocks a crucial isoform of protein kinase C(21). Our 295 finding strongly suggests that macropinocytosis is not only a bypass for PUUV infection 296 but instead a major entry route.
297
Finally, Bafilomycin A, a highly specific inhibitor of a vacuolar-type H + -ATPase and 298 ammonium chloride, a membrane permeable drug that buffers intracellular 299 acidification, were used to block a putative, pH-dependent membrane fusion in cellular 300 endosomes. Again, both compounds reduced virus infection significantly, albeit to a 301 lower extent than EIPA and Rottlerin ( Figure 3A) . Taken together these experiments 313 Infected cells were treated with inhibitors only concomitant with the initial two hours of 314 infection thus predominantly blocking entry, but not viral replication. Other samples 315 were drug exposed during the whole infection time of 24 h, covering both entry and 316 replication phase. Finally, in other samples, the treatment was started after the initial 317 two hours of infection so that replication, but not the viral entry is affected by the 318 compounds. Of note, a significant reduction of the infection was achieved for all three 319 inhibitors when present in the first two hours of infection, but not if the compounds were 320 applied after the initial entry period ( Figure 3B, C, D) . This finding demonstrates that 321 the inhibitors predominantly affect the entry step and strongly support our hypothesis 322 of a clathrin-and macropinocytosis-dominated infection of Vero E6 cells by PUUV. Of
